• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis Inc (NQ: PSNL )

    5.640 +0.640 (+12.80%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Personalis Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Personalis to Present at the Stifel 2024 Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce Third Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
    From Personalis, Inc.
    Via Business Wire
    Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment
    Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research. 
    Via MarketBeat
    Topics Artificial Intelligence ETFs
    Exposures Artificial Intelligence
    Assessing Personalis: Insights From 4 Financial Analysts
    Via Benzinga
    Breaking Down Personalis: 4 Analysts Share Their Views
    Via Benzinga
    Personalis to Participate at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    Why Tempus AI Stock Skyrocketed Nearly 22% Today
    It deepened its involvement in a client and peer. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Personalis and Tempus Announce Expanded Collaboration
    From Personalis, Inc.
    Via Business Wire
    4 Analysts Have This To Say About Personalis
    Via Benzinga
    PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024
    PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Personalis Reports Second Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce Second Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
    From Personalis, Inc.
    Via Business Wire
    ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
    From Personalis, Inc.
    Via Business Wire
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q1 2024
    PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Personalis Reports First Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce First Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
    Tesla found favor with bullish fund manager Cathie Wood, as her firm lapped up Tesla shares following its 10% slide over three sessions. 
    Via Benzinga
    Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
    Via Benzinga
    Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.